Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

 

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
D

Considerations & Challenges for Patients With Hemoglobinopathies Seeking BMT or Cellular-Based Gene Therapies

By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Denise Belcher, Elizabeth Worster, Kelly Heffner
By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Denise Belcher, Elizabeth Worster, Kelly Heffner
0 views
August 14, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Concurrent Sessions
23:26
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Autoimmune Targeted CARs

Feat. M. Milone
16:22
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Combination of CAR-T and Oncolytic Virus in Solid Tumors

Feat. N. Sheppard
13:01
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Imaging Cellular Therapies With PET Imaging

Feat. M. Farwell
15:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Fertility Preservation Options for Pediatric and Young Adult Males

Feat. J. Ginsberg
21:58
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Improving CAR T-Cell Therapies in Lymphoma: The Progress Continues

Feat. J. Svoboda
13:00
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

A Model to Widen Patient Access to BMT and Cell Therapies Across a H…

Feat. R. Richards
31:42
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Implementing Cell Therapy in Community Practice: The Lancaster Gener…

Feat. N. Buescher
05:43
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

An Innovative, Collaborative Approach to Stem Cell Infusion Day Proc…

Feat. A. D’Aprile, T. Ivers
22:50
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Pediatric Case Reviews of Viral Cytotoxic T-Lymphocytes

Feat. B. Mcglynn, S. Barone
25:32
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Considerations & Challenges for Patients With Hemoglobinopathies…

Feat. D. Belcher, E. Worster, K. Heffner
09:56
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Considerations & Challenges for Patients With Malignancies Seeki…

Feat. B. Leibfreid
17:35
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

CAR T-Cells With Dual Targeting of CD19 and CD22

Feat. C. Callahan
16:02
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Proteomic Insights Into Cytokine Release Syndrome and Immune Effecto…

Feat. C. Diorio
19:08
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Novel Approaches for Eradication of AAV Neutralizing Antibodies

Feat. B. Doshi
16:05
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

CAR T-Cells for T-Cell Malignancies

Feat. M. Ruella
18:45
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Genetic Engineering of Hematopoietic Stem Cells to Facilitate CAR T-…

Feat. S. Gill
21:54
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

CAR-T Mechanisms of Resistance: Overcoming Resistance in Lymphoma

Feat. D. Miklos
17:34
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Is There a Role for CAR-T in CLL?

Feat. D. Porter
17:34
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Overview and Updates in CAR-T for Multiple Myeloma

Feat. E. Stadtmauer
16:22
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

CRS and Neurotoxicity: Management and Prophylaxis

Feat. N. Frey
15:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Lymphoma Bispecific Antibody Therapy and Management of CRS

Feat. D. Land, M. Hughes
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
14:18
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Nursing Considerations CAR T-Cell Therapy for Neuroblastoma

Feat. D. Baniewicz
26:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Bispecifics in Multiple Myeloma

Feat. P. Mangan
20:43
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Curative Therapies for Pediatric Acquired Aplastic Anemia

Feat. T. Olson